$GSK

Breakthrough in Respiratory Health: GSK Unveils Long-Term Efficacy of AREXVY Vaccine at CHEST 2024

$GSK GSK plc (LSE|NYSE: GSK) has announced pivotal data from its phase III trial of AREXVY, marking a major advancement…